James Q. Del Rosso
#143,272
Most Influential Person Now
Physician
James Q. Del Rosso's AcademicInfluence.com Rankings
James Q. Del Rossophilosophy Degrees
Philosophy
#7582
World Rank
#10817
Historical Rank
Logic
#4633
World Rank
#5950
Historical Rank

Download Badge
Philosophy
James Q. Del Rosso's Degrees
- PhD Biomedical Sciences Stanford University
Why Is James Q. Del Rosso Influential?
(Suggest an Edit or Addition)James Q. Del Rosso's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. (2007) (193)
- Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne (2013) (191)
- Corticosteroids: options in the era of steroid-sparing therapy. (2005) (141)
- Current modalities and new advances in the treatment of basal cell carcinoma (2006) (135)
- The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. (2011) (121)
- Anti-inflammatory activity of tetracyclines. (2007) (103)
- Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. (2012) (102)
- Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea. (2008) (93)
- Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. (2013) (93)
- Prevalence of superficial fungal infections among sports‐active individuals: results from the Achilles survey, a review of the literature (2001) (85)
- Isotretinoin and Timing of Procedural Interventions: A Systematic Review With Consensus Recommendations (2017) (83)
- Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel† (2019) (79)
- Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. (2007) (76)
- Onychomycosis in children: prevalence and management. (1998) (75)
- Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care. (2013) (73)
- Pathogenesis of acne vulgaris: recent advances. (2009) (70)
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review (2017) (70)
- Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience. (2012) (69)
- Anti-TNF agents for the treatment of psoriasis. (2009) (66)
- Atypical mycobacterial cutaneous infections. (2009) (64)
- The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. (2014) (64)
- Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. (2010) (62)
- Adult seborrheic dermatitis: a status report on practical topical management. (2011) (60)
- Optimizing use of oral antibiotics in acne vulgaris. (2009) (59)
- Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne. (2019) (59)
- Consensus recommendations from the American acne & rosacea society on the management of rosacea, part 4: a status report on physical modalities and devices. (2014) (58)
- Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations (2011) (56)
- Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents. (2013) (56)
- Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. (2014) (55)
- Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. (2011) (55)
- Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 3: a status report on systemic therapies. (2014) (55)
- The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. (2014) (55)
- Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea. (2012) (54)
- Evidence‐based recommendations for the management of acne fulminans and its variants (2017) (52)
- Use of oral isotretinoin in the management of rosacea. (2011) (52)
- Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? (2013) (50)
- Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications. (2016) (50)
- Acne severity grading: determining essential clinical components and features using a Delphi consensus. (2012) (49)
- Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. (2008) (48)
- A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. (2009) (48)
- Management of facial erythema of rosacea: what is the role of topical α-adrenergic receptor agonist therapy? (2013) (48)
- A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris. (2010) (47)
- Management of facial erythema of rosacea: What is the role of topical α-adrenergic receptor agonist therapy? (2013) (47)
- Dermatofibrosarcoma protuberans: a case report and review of the literature. (2008) (45)
- Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria. (2013) (44)
- Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin. (2013) (44)
- Skin cancer in asians: part 1: nonmelanoma skin cancer. (2009) (43)
- Status report on antibiotic resistance: implications for the dermatologist. (2007) (43)
- Evolving perspectives on the etiology and pathogenesis of acne vulgaris. (2015) (43)
- Update on rosacea pathogenesis and correlation with medical therapeutic agents. (2006) (43)
- An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents (2000) (42)
- Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, (2016) (42)
- Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton. (2009) (42)
- American Acne & Rosacea Society rosacea medical management guidelines. (2008) (41)
- The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. (2007) (41)
- Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation. (2015) (41)
- Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. (2008) (40)
- An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea. (2013) (40)
- Skin cancer in asians: part 2: melanoma. (2009) (40)
- Itch: an under‐recognized problem in psoriasis (2019) (39)
- Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant. (2011) (39)
- Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report. (2009) (39)
- Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. (2010) (38)
- Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS). (2019) (38)
- Hepatic Safety of Itraconazole (2002) (37)
- Understanding the Epidermal Barrier in Healthy and Compromised Skin: Clinically Relevant Information for the Dermatology Practitioner: Proceedings of an Expert Panel Roundtable Meeting. (2016) (37)
- Severe neutropenia associated with oral terbinafine therapy. (1998) (37)
- A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines. (2004) (36)
- Medical treatment of rosacea with emphasis on topical therapies (2004) (36)
- Advances in Understanding and Managing Rosacea: Part 2: The Central Role, Evaluation, and Medical Management of Diffuse and Persistent Facial Erythema of Rosacea (2012) (36)
- Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit. (2014) (36)
- A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance. (2007) (35)
- Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea. (2010) (34)
- Examining the importance of laboratory and diagnostic testing when treating and diagnosing onychomycosis (2018) (33)
- Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin. (2012) (33)
- Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. (2007) (32)
- Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. (2011) (31)
- Betamethasone Valerate in Foam Vehicle Is Effective with Both Daily and Twice a Day Dosing: A Single-Blind, Open-Label Study in the Treatment of Scalp Psoriasis (2001) (31)
- Medical treatment of rosacea with emphasis on topical therapies. (2004) (31)
- Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. (2000) (31)
- Comprehensive medical management of rosacea: an interim study report and literature review. (2008) (30)
- A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40 mg modified-release capsules versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. (2020) (30)
- The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection. (2013) (30)
- Status Report on Topical Hypochlorous Acid: Clinical Relevance of Specific Formulations, Potential Modes of Action, and Study Outcomes. (2018) (30)
- Pathways to managing atopic dermatitis: consensus from the experts. (2013) (29)
- A status report on drug-associated acne and acneiform eruptions. (2010) (29)
- Topical antibiotics: therapeutic value or ecologic mischief? (2009) (28)
- The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician? (2013) (27)
- From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology. (2014) (27)
- Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis. (2011) (26)
- Shortcomings in rosacea diagnosis and classification (2017) (26)
- Recently approved systemic therapies for acne vulgaris and rosacea. (2007) (26)
- Tinea capitis in infants: recognition, evaluation, and management suggestions. (2012) (26)
- Healthcare utilization and costs of patients with rosacea in an insured population. (2008) (26)
- Applying the phenotype approach for rosacea to practice and research (2018) (25)
- Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne. (2008) (25)
- Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris. (2007) (25)
- Face to face with oral isotretinoin: a closer look at the spectrum of therapeutic outcomes and why some patients need repeated courses. (2012) (25)
- Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. (2012) (24)
- Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris. (2007) (24)
- Wound care in the dermatology office: where are we in 2011? (2011) (23)
- Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin. (2013) (23)
- Systemic therapy for rosacea: focus on oral antibiotic therapy and safety (2000) (23)
- Optimizing topical therapies for treating psoriasis: a consensus conference. (2010) (22)
- Update on rosacea pathogenesis and correlation with medical therapeutic agents. (2006) (22)
- Adult seborrheic dermatitis: a status report on practical topical management. (2011) (22)
- The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. (2014) (21)
- Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now? (2017) (21)
- The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. (2009) (21)
- Topical corticosteroid application and the structural and functional integrity of the epidermal barrier. (2013) (21)
- Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology (2019) (21)
- Optimal management of papulopustular rosacea: rationale for combination therapy. (2012) (21)
- Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis. (1997) (21)
- Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris. (2015) (20)
- A Closer Look at Seborrheic Keratoses: Patient Perspectives, Clinical Relevance, Medical Necessity, and Implications for Management. (2017) (20)
- Overcoming the Barrier Treatment of Ichthyosis: A Combination-therapy Approach. (2010) (19)
- Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management. (2013) (19)
- Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy. (2007) (19)
- Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations. (2004) (19)
- The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. (2009) (19)
- Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. (2005) (18)
- The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey. (2017) (18)
- Clinical relevance of maintaining the structural and functional integrity of the stratum corneum: why is it important to you? (2011) (18)
- Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach. (2011) (18)
- Management of Truncal Acne Vulgaris with Topical Dapsone 7.5% Gel. (2018) (18)
- The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach. (2012) (17)
- The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel. (2009) (17)
- Minocycline 1.5% Foam for the Topical Treatment of Moderate-to-Severe Papulopustular Rosacea: Results of Two Phase 3, Randomized, Clinical Trials. (2020) (17)
- The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. (2009) (17)
- A status report on the medical management of rosacea: focus on topical therapies. (2002) (17)
- Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence. (2008) (17)
- Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam. (2017) (17)
- Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach. (2014) (16)
- Oral antibiotic drug interactions of clinical significance to dermatologists. (2009) (16)
- A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris. (2013) (16)
- Antifungal agents for onychomycosis: new treatment strategies to improve safety. (2016) (16)
- Efinaconazole 10% solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential. (2013) (15)
- Management of cutaneous rosacea: emphasis on new medical therapies (2014) (15)
- Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation. (2015) (15)
- Clinical significance of brand versus generic formulations: focus on oral minocycline. (2006) (15)
- Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application. (2011) (15)
- Verruciform xanthoma of the glans penis: a benign clinical simulant of genital malignancy. (1993) (15)
- The use of topical imiquimod for the treatment of actinic keratosis: a status report. (2005) (15)
- The use of the new oral antifungal agents, itraconazole, terbinafine, and fluconazole to treat onychomycosis and other dermatomycoses (2001) (15)
- Combination topical therapy in the treatment of acne. (2006) (14)
- Azelaic acid gel 15%: clinical versatility in the treatment of rosacea. (2006) (14)
- Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability. (2008) (14)
- Topical Ivermectin: Data Supporting Dual Modes of Action in Rosacea. (2017) (14)
- Current management of onychomycosis and dermatomycoses (2000) (14)
- Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. (2005) (14)
- Acute generalized exanthematous pustulosis: an enigmatic drug-induced reaction. (2009) (14)
- BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris. (2018) (14)
- Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials. (2022) (13)
- Atopic dermatitis and the stratum corneum: part 3: the immune system in atopic dermatitis. (2013) (13)
- Efficacy, safety, and subject satisfaction of a specified skin care regimen to cleanse, medicate, moisturize, and protect the skin of patients under treatment for acne vulgaris. (2015) (13)
- Effectiveness and safety of modified-release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community-based trial in subgroups based on gender. (2012) (12)
- Topical Corticosteroid Therapy for Psoriasis-A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification. (2020) (12)
- Oral Apremilast for the Treatment of Plaque Psoriasis. (2016) (12)
- Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. (2013) (12)
- Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections (1998) (12)
- The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris. (2017) (12)
- The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection. (2013) (12)
- Multivesicular Emulsion Ceramide-containing Moisturizers: An Evaluation of Their Role in the Management of Common Skin Disorders. (2016) (12)
- Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin. (2011) (12)
- Anti-inflamatory dose doxycycline in the treatment of rosacea. (2009) (12)
- New and emerging topical approaches for actinic keratoses. (2003) (12)
- MONOCLONAL ANTIBODY THERAPIES for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management? (2019) (12)
- New and emerging topical approaches for actinic keratoses. (2003) (12)
- A novel hydrogel vehicle formulated for the treatment of atopic dermatitis. (2007) (11)
- The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. (2006) (11)
- Application of protease technology in dermatology: rationale for incorporation into skin care with initial observations on formulations designed for skin cleansing, maintenance of hydration, and restoration of the epidermal permeability barrier. (2013) (11)
- Topical and oral antibiotics for acne vulgaris. (2016) (11)
- Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid. (2014) (11)
- Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair. (2014) (11)
- Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. (2013) (11)
- Recently approved systemic therapies for acne vulgaris and rosacea. (2007) (11)
- Spotlight on the Use of Nitric Oxide in Dermatology: What Is It? What Does It Do? Can It Become an Important Addition to the Therapeutic Armamentarium for Skin Disease? (2017) (11)
- The use of intermittent itraconazole therapy for superficial mycotic infections: a review and update on the 'one week' approach. (1999) (11)
- Management of truncal acne vulgaris: current perspectives on treatment. (2006) (11)
- Primary carcinosarcoma of the ear: case report and review of the literature. (2009) (10)
- Calciphylaxis: a review. (2008) (10)
- Classification, pathophysiology, and treatment of rosacea (2004) (10)
- Newer topical therapies for the treatment of acne vulgaris. (2007) (10)
- Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis. (2009) (10)
- What is the Role of Benzoyl Peroxide Cleansers in Acne Management?: Do they Decrease Propionibacterium acnes Counts? Do they Reduce Acne Lesions? (2008) (10)
- The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. (2009) (10)
- Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluation. (2015) (10)
- Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference. (2011) (10)
- Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model. (2009) (10)
- The Clinical Relevance of Antibiotic Resistance: Thirteen Principles That Every Dermatologist Needs to Consider When Prescribing Antibiotic Therapy. (2016) (10)
- Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses. (2009) (10)
- Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 2: topical therapies. (2015) (9)
- When Acne is Not Acne. (2016) (9)
- Tretinoin photostability: comparison of micronized tretinoin gel 0.05% and tretinoin gel 0.025% following exposure to fluorescent and solar light. (2013) (9)
- Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study (2019) (9)
- The role of the vehicle in combination acne therapy. (2005) (9)
- Polypodium leucotomos extract: a status report on clinical efficacy and safety. (2015) (9)
- Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis. (2013) (9)
- Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes. (2016) (9)
- Erythropoietic protoporphyria: a case report and literature review. (2010) (9)
- Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis (1997) (9)
- Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data. (2008) (9)
- Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials. (2021) (9)
- Truncal Acne: A Neglected Entity (2019) (9)
- Current approach to acne management: a community-based analysis. (2009) (9)
- Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial. (2010) (8)
- Skin manifestations of drug reactions (2002) (8)
- Ingenol Mebutate Topical Gel A Status Report On Clinical Use Beyond Actinic Keratosis. (2016) (8)
- The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friendly" excipients. (2013) (8)
- An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period. (2019) (8)
- Oral Antibiotic Drug Interactions of Clinical Significance to Dermatologists (2009) (8)
- Sarecycline: A Review of Preclinical and Clinical Evidence (2020) (8)
- Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%). (2010) (8)
- Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data. (2008) (8)
- Androgens, Androgen Receptors, and the Skin: From the Laboratory to the Clinic With Emphasis on Clinical and Therapeutic Implications. (2020) (8)
- Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity. (2018) (8)
- Trolamine-containing topical emulsion: clinical applications in dermatology. (2008) (8)
- Imiquimod 2.5% and 3.75% Cream for the Treatment of Photodamage: A Meta-analysis of Efficacy and Tolerability in 969 Randomized Patients. (2018) (8)
- Patient Awareness of Antimicrobial Resistance and Antibiotic Use in Acne Vulgaris. (2019) (8)
- Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin. (2011) (7)
- Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris. (2020) (7)
- Comprehensive management of patients with superficial fungal infections: the role of sertaconazole nitrate. (2008) (7)
- Topical Cantharidin in the Management of Molluscum Contagiosum: Preliminary Assessment of an Ether-free, Pharmaceutical-grade Formulation. (2019) (7)
- Comparative efficacy and safety results of topical hemostatic powder and sterile compressed foam sponge in second intention healing following Mohs micrographic surgery. (2010) (7)
- A status report on topical tazarotene in the management of acne vulgaris. (2013) (7)
- Wound care in the dermatology office: Where are we in 2011? (2011) (7)
- Management of cutaneous rosacea: emphasis on new medical therapies (2014) (7)
- Rethinking the Journal Impact Factor and Publishing in the Digital Age. (2020) (7)
- Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: oral therapies. (2015) (7)
- Betamethasone Valerate in Foam Vehicle is Effective with Both Daily and Twice a Day Dosing: A Single-Blind, Open-Label Study in the Treatment of Scalp Psoriasis (2001) (7)
- Laser and light-based therapies for acne vulgaris: a current guide based on available data. (2010) (7)
- Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota (2022) (7)
- The Effect of Calcipotriene-Betamethasone Dipropionate Aerosol Foam versus Vehicle on Target Lesions in Moderate Severity Plaque Psoriasis: Focus on Elbows and Knees (2019) (6)
- Tretinoin photostability: comparison of micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to ultraviolet a light. (2012) (6)
- Modern methods to treat superficial fungal disease. (2007) (6)
- Use of Polypodium leucotomas Extract in Clinical Practice: A Primer for the Clinician. (2016) (6)
- Topical and oral antibiotics for acne vulgaris. (2016) (6)
- Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options. (2006) (6)
- An update on newer topical therapies for actinic keratoses: advances and applications. (2003) (6)
- Activity of Dapsone versus Community and Hospital Pathogens from the CANWARD Study. (2016) (6)
- Update from the Scientific Panel on Antibiotic Use in Dermatology: clinical considerations for the dermatologist. (2008) (6)
- Avoiding the legal "blemish": medicolegal pitfalls in dermatology. (2009) (6)
- The Use of Oral Antibiotics in the Management of Rosacea (2019) (5)
- Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy. (2007) (5)
- Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam. (2017) (5)
- Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials (2021) (5)
- Oral cephalosporin antibiotics: an overview of clinical pharmacology and dermatologic applications. (2003) (5)
- The treatment of viral infections and nonmelanoma skin cancers. (2007) (5)
- The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid. (2006) (5)
- Halobetasol 0.01%/Tazarotene 0.045% Fixed-combination Lotion in the Treatment of Plaque Psoriasis: Sensitization and Irritation Potential. (2019) (5)
- Photodynamic Therapy with 5-aminolevulinic Acid 10% Gel and Red Light for the Treatment of Actinic Keratosis, Nonmelanoma Skin Cancers, and Acne: Current Evidence and Best Practices. (2021) (5)
- A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses. (2012) (5)
- Biologic Therapies in the Treatment of Hidradenitis Suppurativa (2010) (5)
- An Aluminum Magnesium Hydroxide Stearate-based Skin Barrier Protection Cream Used for the Management of Eczematous Dermatitis: A Summary of Completed Studies. (2008) (4)
- The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. (2006) (4)
- A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide. (2009) (4)
- Mycetoma clinically masquerading as squamous cell carcinoma: case report and literature review. (2009) (4)
- Comprehensive management of patients with superficial fungal infections: the role of sertaconazole nitrate. (2008) (4)
- Topical therapy for acne in women: is there a role for clindamycin phosphate-benzoyl peroxide gel? (2014) (4)
- An update on newer topical therapies for actinic keratoses: advances and applications. (2003) (4)
- Revisiting the Beneficial Effects of Estrogen on the Skin: A Comprehensive Review of the Literature and a Look to the Future (2018) (4)
- Gaps and recommendations for clinical management of truncal acne from the Personalising Acne: Consensus of Experts panel (2021) (4)
- Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair. (2014) (4)
- Use of Topical Tazarotene for the Treatment of Acne Vulgaris in Pregnancy: A Literature Review. (2020) (4)
- Lidose-Isotretinoin Administered Without Food Improves Quality of Life in Patients With Severe Recalcitrant Nodular Acne: An Open-Label, Single-Arm, Phase IV Study. (2020) (4)
- Retinoic acid receptors and topical acne therapy: establishing the link between gene expression and drug efficacy. (2002) (4)
- Skin manifestations of drug reactions. (2002) (4)
- Not all topical corticosteroids are created equal! Optimizing therapeutic outcomes through better understanding of vehicle formulations, compound selection,and methods of application. (2012) (4)
- Oral Antibiotics in Dermatology: A Practical Overview with Clinically Relevant Correlations and Management Suggestions (2018) (4)
- The Role of Skin Care and Maintaining Proper Barrier Function in the Management of Rosacea (2010) (4)
- A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of acne vulgaris: aesthetic characteristics, patient preference considerations, and impact on compliance with treatment. (2009) (4)
- Topical imiquimod therapy for actinic keratosis: is long-term clearance a realistic benefit? (2008) (4)
- Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis. (2018) (4)
- Clinical efficacy & safety of oral Polypodium leucotomos extract for photoprotection: A systematic review (2018) (4)
- Selection of therapy for acne vulgaris: balancing concerns about antibiotic resistance. (2008) (4)
- Acne and the Internet. (2016) (4)
- Perspectives on seborrheic dermatitis: looking back to move ahead. (2009) (4)
- Perspectives on seborrheic dermatitis: looking back to move ahead (2009) (4)
- Defining criteria used to evaluate response to treatment of acne vulgaris. (2006) (3)
- Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes. (2016) (3)
- Weight-based Dosing and Extended-release Formulation of Minocycline Tablets: Is There Clinical Significance? (2009) (3)
- What's New in the Medicine Cabinet?: A Panoramic Review of Clinically Relevant Information for the Busy Dermatologist. (2014) (3)
- Management of tinea capitis. A status report. (1999) (3)
- Medical treatment of rosacea with emphasis on topical therapies (2004) (3)
- Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex. (2021) (3)
- Factors influencing optimal skin care and product selection (2005) (3)
- The use of topical azelaic acid 15% gel or metronidazole 0.75% gel for the treatment of rosacea: evaluation of a single-site comparative trial subset 1 (2004) (3)
- Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea. (2020) (3)
- Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin. (2018) (3)
- Topical Oxymetazoline Hydrochloride Cream 1% for the Treatment of Persistent Facial Erythema of Rosacea in Adults: A Comprehensive Review of Current Evidence. (2021) (3)
- Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits (2021) (3)
- Topical metronidazole combination therapy in the clinical management of rosacea. (2005) (3)
- Sarecycline treatment for acne vulgaris: Rationale for weight‐based dosing and limited impact of food intake on clinical efficacy (2021) (3)
- Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel for the Treatment of Acne Vulgaris: Which Patients are Most Likely to Benefit the Most? (2015) (3)
- SARECYCLINE AND THE NARROW-SPECTRUM TETRACYCLINE CONCEPT: Currently Available Data and Potential Clinical Relevance in Dermatology. (2020) (3)
- Application of Nail Polish During Topical Management of Onychomycosis: Are Data Available to Guide the Clinician About What to Tell Their Patients? (2016) (3)
- Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05. (2017) (3)
- Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts panel (2021) (3)
- Use of Polypodium leucotomas Extract in Clinical Practice: A Primer for the Clinician. (2016) (3)
- Capsule Commentaries: Drug Reaction Considerations with Oral Minocycline (2018) (3)
- Treatment of Darier's disease with isotretinoin: report of a case. (1986) (3)
- Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application. (2014) (3)
- Oral cephalosporin antibiotics: an overview of clinical pharmacology and dermatologic applications. (2003) (3)
- Tackling the anterior nares and other sites of colonization: implications for the dermatologist. (2007) (3)
- Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications. (2010) (3)
- The ORCA (Oracea for rosacea: a community-based assessment) trial: a large-scale, phase 4 trial in papulopustular rosacea. (2010) (3)
- Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy (1996) (3)
- Topical Treatment of Skin Cancer (2011) (3)
- Antibiotic resistance: overview and significance in dermatology. (2005) (2)
- Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily (2021) (2)
- The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream. (2012) (2)
- TREATMENT OF ONYCHOMYCOSIS AND TINEA PEDIS WITH INTERMITTENT ITRACONAZOLE THERAPY (1996) (2)
- Cephalosporins in dermatology. (2003) (2)
- Topical tazarotene in acne vulgaris: treatment approaches. (2004) (2)
- The Personalised Acne Care Pathway—Recommendations to guide longitudinal management from the Personalising Acne: Consensus of Experts (2021) (2)
- Therapeutic experience with cefdinir in the treatment of uSSSIs (2006) (2)
- Future trends in the treatment of rosacea (2005) (2)
- When do efficacy outcomes in clinical trials correlate with clinical relevance? analysis of clindamycin phosphate 1.2%-benzoyl peroxide 3.75% gel in moderate to severe acne vulgaris. (2016) (2)
- Applications of Topical Oak Bark Extract in Dermatology: Clinical Examples and Discussion (2019) (2)
- Prevalence and Demographics of Truncal Involvement Among Acne Patients: Survey Data and a Review of the Literature. (2022) (2)
- Drug interactions of clinical significance to dermatologists: A primer and update (2000) (2)
- Reply to "Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea". (2014) (2)
- Cephalosporins in dermatology (2004) (2)
- Solitary sclerotic fibroma. (2009) (2)
- Ceramide- and Keratolytic-containing Body Cleanser and Cream Application in Patients with Psoriasis: Outcomes from a Consumer Usage Study. (2019) (2)
- Topical retinoids in the management of acne: the best path to clear results. (2004) (2)
- A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of acne vulgaris: aesthetic characteristics, patient preference considerations, and impact on compliance with treatment. (2009) (2)
- The changing face of challenges in the management of acne and rosacea. (2014) (2)
- Commentaries on ‘Minocycline for acne vulgaris: efficacy and safety’ with a response from the review authors (2011) (2)
- Topical Corticosteroid Therapy for Psoriasis-A Review of Clobetasol Propionate 0.025% Cream and the Clinical Relevance of Penetration Modification. (2020) (2)
- The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review (2021) (2)
- The Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles: Vehicle Characteristics Can Influence and Improve Patient Outcomes (2019) (2)
- Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide/Clindamycin Combination Product: An Investigator-Blind, Randomized, Parallel-Group Study. (2008) (2)
- Reply to "Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea". (2014) (2)
- Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction. (2008) (2)
- Topical management of acne vulgaris using a combination gel formulation: benzoyl peroxide 2.5%–clindamycin phosphate 1.2% gel (2010) (2)
- Clindamycin phosphate-tretinoin combination gel revisited: status report on a specific formulation used for acne treatment. (2017) (2)
- The use of foam vehicle topical corticosteroid formulations in combination with other topical agents: a clinical perspective based on available studies and observational use (2004) (1)
- JAK inhibitors in the treatment of atopic dermatitis (2022) (1)
- More from the Pipeline of Clinical Research on SELECTED SYSTEMIC THERAPIES FOR ATOPIC DERMATITIS. (2019) (1)
- Efficacy and Safety of Microencapsulated Benzoyl Peroxide 3% and Microencapsulated Tretinoin 0.1% (E-Bpo/E-Atra) in Acne Vulgaris: Results from Two Randomized Controlled Clinical Trials (2021) (1)
- The treatment of rosacea. (2004) (1)
- A qualitative and quantitative assessment of the application and use of topical acne medication by patients. (2005) (1)
- Updates & perspectives on management of common dermatologic disorders. (2007) (1)
- What Is PFE? It May Just Be Time You Found Out.... (2019) (1)
- Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream. (2014) (1)
- The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream. (2013) (1)
- Advancements in topical therapy (2022) (1)
- Cutaneous rosacea: a thorough overview of pathogenesis, clinical presentations, and current recommendations on management (2016) (1)
- LB784 Acne fulminans and its variants: Evidence-based expert panel recommendations (2016) (1)
- More from the Pipeline of Clinical Research on SELECTED SYSTEMIC THERAPIES FOR ATOPIC DERMATITIS. (2019) (1)
- Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report. (2021) (1)
- Tapinarof Cream for the Treatment of Plaque Psoriasis: Efficacy and Safety by Baseline Disease Characteristics and Skin Type in a Phase 2b Randomized Study (2019) (1)
- Furuncular Cutaneous Myiasis (1)
- 17800 Open-label extension study evaluating the long-term safety, efficacy, and tolerability of FMX103 1.5% topical minocycline foam in the treatment of moderate to severe facial papulopustular rosacea (2020) (1)
- Status Report on Oral Isotretinoin in the Management of Acne Vulgaris: Why All the Discussion about Drug Absorption and Relapse Rates? (2013) (1)
- Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies (2019) (1)
- Adapalene 0.3%/benzoyl peroxide 2.5% gel plus oral doxycycline is an effective and safe option for oral isotretinion candidates with severe inflammatory acne (non-nodulocystic/non-conglobate) (2018) (1)
- Polypodium Leucotomos Extract (PLE): New Study Gives Evidence-based Insight into "Ain't Nothing Like the Real Thing". (2019) (1)
- Retinoid-Induced Flaring in Patients with Acne Vulgaris: Does It Really Exist?: A discussion of data from clinical studies with a gel formulation of clindamycin phosphate 1.2% and tretinoin 0.025%. (2008) (1)
- Olumacostat Glasaretil (DRM01) for the Treatment of Acne Vulgaris: Primary Results from the DRM01-ACN02 Phase 2b Randomized Controlled Trial (2017) (1)
- The use of topical imiquimod for cutaneous epithelial malignancies: clinical experience, optimal application regimens, patient follow-up and tolerability assessments (2004) (1)
- An Update on the Latest Developments in Nonsteroidal Topical Therapy for Atopic Dermatitis. (2020) (1)
- Rapid Improvement with BPX-01 Minocycline Topical Gel in the Treatment of Moderate-to-Severe Inflammatory Acne Vulgaris: a Randomized, Double-Blind, Vehicle-Controlled Study (2017) (1)
- Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies (2020) (1)
- SUPPLEMENT INDIVIDUAL ARTICLE: Optimizing Skin Care in Acne Treatment - Evaluation of a Designated Cleanser and Moisturizer Regimen With Improvement in Clinical Outcomes. (2022) (1)
- Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study) (2023) (0)
- Patient Satisfaction with Tapinarof Cream 1% Once Daily for Plaque Psoriasis in a Long-Term Extension Trial (2022) (0)
- Lebrikizumab Monotherapy Reduces Flares in Patients with Moderate-to-Severe Atopic Dermatitis (2023) (0)
- Critical Evaluation of Benzoyl Peroxide in Rosacea: Old Challenges and New Clinical Opportunities With Encapsulated Benzoyl Peroxide (2022) (0)
- Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis (2021) (0)
- Hyperkeratotic papular eruptions on legs, arms, and back (2010) (0)
- MONOCLONAL ANTIBODY THERAPIES for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management? (2019) (0)
- Early Onset of Efficacy Using a 1% and 2% Topical Minocycline Gel for the Treatment of Rosacea: a Small Open Label Study (2018) (0)
- Efficacy and Tolerability of Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis Involvement on the Face, Intertriginous, or Genital Areas: Pooled Results From Phase 3 Trials (DERMIS-1 and DERMIS-2) (2022) (0)
- Incorporating the use of TNF inhibitors in the management of psoriasis from the perspective of the community dermatologist (2004) (0)
- 33463 Pooled efficacy and safety results from the DERMIS-1 and DERMIS-2 phase 3 trials of once-daily roflumilast cream 0.3% by baseline body surface area (2022) (0)
- What Is PFE? It May Just Be Time You Found Out.... (2019) (0)
- A New Frontier in Acne Treatment: Encapsulated Benzoyl Peroxide and Tretinoin (2022) (0)
- Effect of Calcipotriene/Betamethasone Dipropionate 0.005%/0.064% Foam on Target Lesions in Plaque Psoriasis: A Post-Hoc Analysis (2020) (0)
- 将酒渣鼻表现型方法应用于实践和研究 (2018) (0)
- Topical Azole Antimycotics for Superficial Fungal Infections (2007) (0)
- Drug Actions , Reactions , and Interactions Cephalosporin Therapy in the Management of Uncomplicated Skin and Soft Tissue Infections (0)
- Activity of Dapsone Versus Community and Hospital Bacterial Pathogens from the CANWARD Study (2017) (0)
- Why are dermatologists still talking about acne? Because so many people have it... and we are always seeking better ways to manage it. (2011) (0)
- Polypodium Leucotomos Extract (PLE): New Study Gives Evidence-based Insight into "Ain't Nothing Like the Real Thing". (2019) (0)
- Once-Daily Halobetasol Propionate 0.01% Lotion for Moderate-to-Severe Plaque Psoriasis: Phase 3 Analysis of Hispanic Participants (2021) (0)
- Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea (2022) (0)
- JCADermatology Update on the Management of ACNE and ROSACEA from the American Acne and Rosacea Society ( AARS ) (2019) (0)
- Del Rosso , DO , FAOCD Benzoyl Peroxide Microsphere Formulations : What is the Science Supporting Microsphere Vehicle Technology and Clinical Use ? (2009) (0)
- Therapeutic experience with cefdinir in the treatment of uSSSIs. (2006) (0)
- Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity (2022) (0)
- Preface. Face to Face with Acne in 2016 and Beyond. (2016) (0)
- Who Is Accountable When Patients Do Not Achieve Successful Treatment for Their Acne (2018) (0)
- 13882 Trifarotene 50 μg/g cream: An effective and safe treatment for moderate facial and truncal acne (2020) (0)
- Once-Daily Halobetasol Propionate 0.01% Lotion for Moderate-to-Severe Plaque Psoriasis: Phase 3 Analysis of Hispanic Participants. (2021) (0)
- A Randomized, Controlled Trial of Trifarotene Plus Doxycycline for Severe Acne Vulgaris. (2022) (0)
- Acne Vulgaris and Rosacea (2019) (0)
- Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series (2022) (0)
- Survey Study of Dermatologist and Patient Satisfaction with Halobetasol Propionate Lotion for the Treatment of Plaque Psoriasis (2017) (0)
- Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients (2020) (0)
- Contempo 1997: Dermatology (1997) (0)
- Considerations in the Management of Actinic Keratoses: The Importance of Adherence and Persistence to Therapy (2021) (0)
- Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety (0)
- Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study) (2023) (0)
- Long-term Safety and Efficacy of Fixed-Combination Halobetasol Propionate and Tazarotene Lotion in Patients With Clinically Meaningful Improvement in Plaque Psoriasis (2021) (0)
- What's New in the Medicine Chest? Part 2 (2018) (0)
- Treatment of seborrheic dermatitis: focus on the use of pimecrolimus (2004) (0)
- LB756 Patient-reported outcomes for sarecycline effectiveness in Acne Vulgaris in real-world settings: PROSES study protocol (2021) (0)
- Systemic Therapies for Acne Vulgaris and Rosacea (2007) (0)
- An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period (2018) (0)
- The Future of Contract Research Organizations in Dermatology and Aesthetic Research. (2022) (0)
- The reemergence of sulfacetamide-sulfur formulations in the treatment of common inflammatory facial dermatoses: focus on the role of cleansers as adjunctive therapy in the treatment of rosacea (2004) (0)
- An Expert Panel Questionnaire for Assessing Patient-Reported and Caregiver-Reported Outcomes in Acne Vulgaris (2022) (0)
- Evaluating physician & patient perspectives regarding managment of seborrheic dermatitis: focus on antifungal shampoo therapy with ciclopirox (2004) (0)
- Cutaneous rosacea: a thorough overview of pathogenesis, clinical presentations, and current recommendations on management (2016) (0)
- 27124 Impact of body mass index (BMI) on the efficacy and safety of halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion in patients with plaque psoriasis (2021) (0)
- 35165 Efficacy, tolerability, and cosmetic acceptability of an acne regimen specifically designed for sensitive skin (2022) (0)
- Improvements in Acne and Skin Oiliness with Tazarotene 0.045% Lotion in Patients with Oily Skin. (2021) (0)
- What's New in the Medicine Chest? Part 1 (2017) (0)
- Applying the phenotype approach for rosacea to practice and research (2018) (0)
- Contempo 1997: dermatology. (1997) (0)
- Comprar Drug Actions, Reactions, and Interactions, An Issue of Dermatologic Clinics | J. Del Rosso | 9781416043058 | Saunders (2007) (0)
- Adapting to Changes in Acne Management: Take One Step at a Time. (2022) (0)
- Pipeline Perspectives and Therapy Updates. (2020) (0)
- Clinically Important Considerations with the Use of Oral Doxycycline (2017) (0)
- What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials. (2013) (0)
- Just Like Rock and Roll, Topical Medications for Psoriasis Are Here to Stay. (2022) (0)
- Capsule Commentaries: Selected Oral Antifungal Drug-Drug Interactions with Itraconazole and Terbinafine (2018) (0)
- Pipeline Perspectives and Therapy Updates. (2020) (0)
- 13509 Integrated safety analysis of FMX103 1.5% topical minocycline foam for the treatment of moderate to severe papulopustular rosacea: Results from two phase 3 studies (2020) (0)
- Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study Evaluating Efficacy and Safety (2021) (0)
- What data support the use of minocycline in the treatment of acne vulgaris ? (2006) (0)
- Investigator global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S in PROSES study: Analysis by concomitant medication (2023) (0)
- Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS). (2020) (0)
- Investigating Treatment of Primary Axillary Hyperhidrosis With a Topical Retrometabolic Anticholinergic Drug (2021) (0)
- Anti-Inflammatory Dose Doxycycline (40 mg Delayed Release) Once Daily Versus Doxycycline 100 mg Once Daily for Rosacea (2009) (0)
- Editorial message July highlights (2016) (0)
- Management of Acne Vulgaris , Rosacea , and Perioral Dermatitis (2010) (0)
- An Expert Panel Questionnaire for Assessing Patient-Reported and Clinician-Reported Outcomes in Actinic Keratosis (2022) (0)
- Sarecycline Demonstrates Narrow spectrum Antibacterial Activity and Anti inflammatory Effect in Animal Models (2021) (0)
- A current appraisal of drug interactions of significance in clinical practice: focus on antifungal therapeutic agents used in the treatment of superficial mycoses (2004) (0)
- Disorders of Hair (2013) (0)
- Efficacy and Saftey of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Doxycycline in Subjects with Severe Inflammatory Acne (Non-Nodulocystic) that are Candidates for Oral Isotretinoin (2017) (0)
- 25843 Tapinarof cream 1% once daily for plaque psoriasis: Patient-reported outcomes from two pivotal phase 3 trials (2021) (0)
- Treatment of Darier's disease with isotretinoin: Report of a case (1986) (0)
- Emerging therapies in pediatric atopic dermatitis patients (2022) (0)
- The Scientific Panel on Antibiotic Usage in Dermatology ( SPAUD ) Part II : Continuation of A Summary Report On Usage Patterns , Management Challenges and Recommendations (0)
- Clinical Manifestations and Management Considerations of Psoriasis Affecting The Nail Unit (2018) (0)
- 34970 Efficacy, tolerability, and consumer perception of a skincare regimen in patients with uneven skin tone (2022) (0)
- The clinical value of benzoyl peroxide cleanser: formulation characteristics, method of use, drug deposition and clinical efficacy 1 ☆ (2004) (0)
- Ceramide- and Keratolytic-containing Body Cleanser and Cream Application in Patients with Psoriasis: Outcomes from a Consumer Usage Study. (2019) (0)
- Advances in Acne Management (2016) (0)
- Why is it that the biggest resistance with fighting the battle against bacterial resistance seems to fall on dermatology clinicians? (2020) (0)
- The use of oral tetracyclines for the treatment of common inflammatory facial dermatoses: perspectives on antibiotic vs anti-inflammatory dosing regimens (2004) (0)
- Avoiding Prescribing Problems in Penicillin-Allergic Patients New information about cross-reactivity (0)
- Patient-Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis in Real-world Settings: PROAK Study Protocol (2022) (0)
- Why is it that the biggest resistance with fighting the battle against bacterial resistance seems to fall on dermatology clinicians (2020) (0)
- AARS HOT TOPICS MEMBER NEWSLETTER (2022) (0)
- Application of Nail Polish During Topical Management of Onychomycosis: Are Data Available to Guide the Clinician About What to Tell Their Patients? (2016) (0)
- Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion. (2023) (0)
- Painful Subcutaneous Nodules of the Lower Extremities (2010) (0)
- Acne and rosacea. (2008) (0)
- Efficacy and Safety of Tazarotene 0.045% Lotion in Caucasian Adults With Moderate-to-Severe Acne. (2022) (0)
- The Personalised Acne Treatment Tool (PATT) – Recommendations to facilitate a patient-centered approach to acne management from the Personalising Acne: Consensus of Experts (PACE) (2023) (0)
- Efficacy and Safety of Tazarotene 0.045% Lotion in White Adults with Moderate-to-Severe Acne (2021) (0)
- Comprar Year Book of Dermatology and Dermatological Surgery 2010 | J. Del Rosso | 9780323068277 | Mosby (2010) (0)
- What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials. (2013) (0)
- Antibiotic Resistance Considerations of Importance to Clinical Dermatologists (2017) (0)
- CONTEMPO 1997 : DERMATOLOGY. AUTHORS' REPLY (1997) (0)
- Status Report on the Safety of Topical Dapsone Therapy for Dermatologic Disease (2018) (0)
- 专家组为医生提供治疗酒渣鼻的新建议 (2020) (0)
- 32846 Dual study: Trifarotene plus doxycycline has proven efficacy and safety in severe acne vulgaris (2022) (0)
- Message from the guest editor. (2012) (0)
- Understanding rosacea‐prone skin: Understanding the correlations between clinical manifestations and underlying pathophysiology (2021) (0)
- Overstating Conclusions from Population-Based Data: Be Careful What You Wish For! (2016) (0)
- Impact of acne on social functioning, emotional functioning, and activities of daily living among patients with moderate to severe non-nodular acne vulgaris administered sarecycline in real-world community practices across the U.S. (PROSES Study) (2022) (0)
- Effective Treatment of Inflammatory Lesions of Rosacea with Subantibiotic Dose Doxycycline Irrespective of Patient Weight or Baseline Lesion Count Severity. (2022) (0)
- Examining the available evidence of topical retinoid use in acne vulgaris: does initial exacerbation of acne commonly precede improvement and is it necessary to induce irritation in order to achieve clinical benefit? 1 (2004) (0)
- Panel provides new recommendations and advice for doctors on rosacea (2020) (0)
- The Future of Contract Research Organizations in Dermatology and Aesthetic Research. (2022) (0)
- Who Is Accountable When Patients Do Not Achieve Successful Treatment for Their Acne? (2018) (0)
- We are making progress with both acne and rosacea--but, let's face it! We still have a long way to go. (2010) (0)
- Tazarotene 0.045% Lotion for Females With Acne: Analysis of Two Adult Age Groups. (2022) (0)
- Acne symptoms and impact of acne on social functioning, emotional functioning, and activities of daily living (ADL) among pediatric patients with moderate to severe non-nodular Acne Vulgaris (AV) in community practices across the U.S: PROSES study (2023) (0)
- Management of Acne & Rosacea: Working Toward the Same Goals…Facing New Challenges. (2015) (0)
- Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Efficacy by Baseline Disease Characteristics and Demographics in Two Pivotal Phase 3 Trials (2021) (0)
- An Update on the Latest Developments in Nonsteroidal Topical Therapy for Atopic Dermatitis. (2020) (0)
- The new and old: Atopic dermatitis biologics (2022) (0)
- The impact of atopic dermatitis on the quality of life (2022) (0)
- Never Give Up! Continued Progress in Development of Topical Therapies for Acne Is a Good Thing. (2022) (0)
- Antibiotic resistance: overview and significance in dermatology. (2005) (0)
- Introduction to atopic dermatitis (2021) (0)
- Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Phase 2 Study of the First Triple-Combination Drug (2022) (0)
- Patient Reported Outcomes (PROs) and Investigator Global assessment (IGA) of Acne Vulgaris among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in real-world community practices across the U.S. (PROSES Study) (2022) (0)
- Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections. (1998) (0)
- LB938 Efficacy of FMX101 4% topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Integrated summary from three phase 3 studies (2020) (0)
- Increased Uniformity in Diagnostic Accuracy of Pigmented Lesions Using Electrical Impedance Spectroscopy Information. (2021) (0)
- Investigator global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: PROSES study analysis by gender and age (2023) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With James Q. Del Rosso?
James Q. Del Rosso is affiliated with the following schools: